s.ivaturi
TL2 Moderator · Turku
Contributes reviews on supplier material. Based in Turku.
Joined 5 May 2025 · last posted 19d
81 posts, newest first. Showing up to 150.
-
A critique that turned out to be unfair, retracted by its author Replied, post #27 · Evidence › Study critique · 9 Jul 2026 · 0 likes post #26 is right about the mechanism and I think understates the practical bit. Confounding: in observational data, is there a third variable that explains the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #117 · Practice › Reconstitution · 9 Jul 2026 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #111 · Start Here › How to Ask · 9 Jul 2026 · 6 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Sulfonylureas: the interaction most worth taking seriously Replied, post #8 · Practice › Interactions · 5 Jul 2026 · 16 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Journal club: what we got wrong in an earlier session Replied, post #27 · Evidence › Journal club · 25 Jun 2026 · 22 likes Picking up post #24: that is the part I would want checked first. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg…
-
What steady state means for the decision to escalate Replied, post #18 · Practice › Dosing & titration · 24 Jun 2026 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Research-use-only status: what it means legally and practically Replied, post #60 · Compounds › Other compounds · 18 Jun 2026 · 12 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
CJC-1295 with and without DAC: what the modification does Replied, post #86 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 5 likes Coming back to post #84, because the follow-up matters more than the original answer. CJC-1295 with and without DAC: the version with a drug affinity complex binds…
-
Transporting a vial for a weekend away — a second dataset Replied, post #80 · Practice › Storage & stability · 12 Jun 2026 · 18 likes Coming back to post #78, because the follow-up matters more than the original answer. Temperature excursions: if a vial sat at room temperature for a time, the question…
-
Tracking a shortage from primary sources rather than rumour Replied, post #44 · Access › Shortages · 10 Jun 2026 · 22 likes Picking up post #41: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #36 · Analytics › Mass spectrometry · 9 Jun 2026 · 0 likes post #35 is right about the mechanism and I think understates the practical bit. Resolution: "high resolution" commonly means
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #73 · Practice › Reconstitution · 6 Jun 2026 · 28 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 31 May 2026 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #64 · Practice › Administration · 16 May 2026 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Prescription requirements and telehealth models — a second dataset Replied, post #25 · Sourcing › Regulatory · 10 May 2026 · 1 like Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #32 · Analytics › COA interpretation · 3 May 2026 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #106 · Practice › Storage & stability · 28 Apr 2026 · 14 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Sample handling between despatch and injection Replied, post #67 · Analytics › Method validation · 25 Apr 2026 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #108 · Analytics › Mass spectrometry · 23 Apr 2026 · 1 like post #107 is right about the mechanism and I think understates the practical bit. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses…
-
Official shortage notices and what they authorise Replied, post #14 · Access › Shortages · 20 Apr 2026 · 19 likes post #13 answers the question as asked. The question underneath it is different. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #91 · Practice › Interactions · 18 Apr 2026 · 0 likes Coming back to post #89, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #148 · Access › Pricing · 16 Apr 2026 · 24 likes I read post #146 twice before replying, because I had assumed the opposite. List prices versus negotiated prices: the price a pharmaceutical company publishes and the…
-
Fasting versus non-fasting and which tests care Replied, post #5 · Clinical › Bloodwork · 29 Mar 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #58 · Research Methods › N-of-1 designs · 25 Mar 2026 · 0 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #96 · Lounge › Introductions · 17 Mar 2026 · 0 likes Picking up post #93: that is the part I would want checked first. No spam: introductions are not a place to advertise commercial products or services. That is a rules…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #73 · Start Here › How to Ask · 13 Mar 2026 · 2 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Reading a regulatory notice rather than an article about it Replied, post #3 · Sourcing › Regulatory · 10 Mar 2026 · 4 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #126 · Compounds › Semaglutide · 22 Feb 2026 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #3 · Practice › Dosing & titration · 6 Feb 2026 · 25 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #9 · Evidence › Study critique · 27 Jan 2026 · 0 likes On post #5 — agreed on the reasoning, with one qualification. What makes a methodological criticism substantive: it identifies a specific feature of the design that…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #59 · Access › International · 17 Jan 2026 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #42 · Practice › Side effects · 16 Jan 2026 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Solubility limits and what a cloudy solution is telling you Started this topic · Pharmacology › Formulation chemistry · 28 Dec 2025 · 0 likes Solubility limits and what a cloudy solution is telling you — setting out what I have, and where I think it stops being reliable. A documentation question rather than…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #60 · Compounds › Oral incretins · 20 Dec 2025 · 1 like On post #56 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Journal club: LEADER as the historical anchor Replied, post #8 · Evidence › Journal club · 30 Nov 2025 · 12 likes This follows post #5 rather than contradicting it. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
-
Waist circumference technique and its repeatability Replied, post #18 · Outcomes › Progress reports · 20 Nov 2025 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #20 · Analytics › HPLC & UHPLC · 15 Nov 2025 · 0 likes Coming back to post #18, because the follow-up matters more than the original answer. Gradient slope is the single biggest driver of apparent purity differences. A…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #29 · Clinical › Special populations · 11 Nov 2025 · 18 likes I read post #27 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #3 · Data & Tools › Calculators · 7 Nov 2025 · 0 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #11 · Practice › Dosing & titration · 13 Oct 2025 · 11 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #103 · Evidence › Study critique · 15 Sep 2025 · 13 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Payment method and the leverage it gives you, ranked Replied, post #13 · Sourcing › Payments · 15 Sep 2025 · 11 likes Escrow services: some third-party services hold payment until the buyer confirms receipt. They add cost but reduce risk if the supplier is unknown.
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #28 · Analytics › Method validation · 2 Sep 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #44 · Analytics › Mass spectrometry · 29 Aug 2025 · 32 likes On post #40 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
What a documentation review can and cannot tell you Replied, post #79 · Sourcing › Independent verification · 19 Aug 2025 · 17 likes On post #75 — agreed on the reasoning, with one qualification. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells…
-
Which panel is worth repeating and which is worth ignoring Replied, post #85 · Clinical › Bloodwork · 15 Aug 2025 · 3 likes On post #81 — agreed on the reasoning, with one qualification. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than…
-
Follow-up: Why appetite effects are mostly central Replied, post #16 · Pharmacology › Receptor biology · 12 Aug 2025 · 30 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
[2026 update] Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #2 · Compounds › Tirzepatide · 11 Aug 2025 · 4 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Coming back to: When "no data" is the complete and final answer Replied, post #80 · Compounds › Other compounds · 11 Aug 2025 · 2 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
A request that was declined, and the reasoning — a second dataset Replied, post #18 · Documentation › Wiki requests · 7 Aug 2025 · 22 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Antibiotics and a course of something with delayed emptying Replied, post #100 · Practice › Interactions · 25 Jul 2025 · 12 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
A field-by-field walk through a certificate of analysis Replied, post #104 · Analytics › COA interpretation · 17 Jul 2025 · 10 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #29 · Practice › Reconstitution · 7 Jul 2025 · 2 likes On post #25 — agreed on the reasoning, with one qualification. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #65 · Evidence › Trials · 30 Jun 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #25 · Analytics › Method validation · 27 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Titles that describe the question, not the situation Replied, post #28 · Start Here › How to Ask · 14 Jun 2025 · 26 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #97 · Data & Tools › Calculators · 28 May 2025 · 0 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #8 · Sourcing › Payments · 8 May 2025 · 25 likes On post #4 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Coming back to: Oxidation pathways for methionine and tryptophan Replied, post #6 · Analytics › Impurities & related substances · 6 May 2025 · 13 likes post #5 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Titles that describe the question, not the situation Replied, post #3 · Start Here › How to Ask · 27 Apr 2025 · 3 likes Worth separating two things that the opening post runs together. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which…
-
A report I filed that turned out to be wrong, and the correction Replied, post #24 · Sourcing › Vendor reports · 23 Apr 2025 · 0 likes Picking up post #21: that is the part I would want checked first. Date the report: when the analysis was done matters. Material can degrade in storage. A report from…
-
Adjudicated events and why the definition matters — the long version Replied, post #80 · Evidence › Trials · 4 Apr 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #141 · Sourcing › Regulatory · 5 Mar 2025 · 15 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #22 · Evidence › Meta-analyses · 29 Jan 2025 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #44 · Sourcing › Red flags · 26 Jan 2025 · 27 likes Coming back to post #42, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #29 · Compounds › Semaglutide · 16 Jan 2025 · 0 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
UK access routes, dated and sourced — a second dataset Replied, post #27 · Regional › UK & Ireland · 15 Jan 2025 · 0 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #22 · Pharmacology › Receptor biology · 10 Jan 2025 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #7 · Compounds › Semaglutide · 24 Dec 2024 · 18 likes post #6 is right about the mechanism and I think understates the practical bit. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #24 · Data & Tools › Calculators · 19 Dec 2024 · 24 likes post #23 answers the question as asked. The question underneath it is different. Mass error checking: enter your observed mass and theoretical mass and check whether…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #44 · Sourcing › Regulatory · 2 Dec 2024 · 1 like Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Washout with a one-week half-life: the arithmetic Replied, post #35 · Research Methods › N-of-1 designs · 29 Nov 2024 · 29 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #41 · Clinical › Special populations · 23 Nov 2024 · 7 likes Worth separating two things that post #37 runs together. Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but…
-
Buffers, pH and why a formulation is a formulation Replied, post #14 · Pharmacology › Formulation chemistry · 30 Oct 2024 · 0 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #4 · Compounds › Semaglutide · 29 Oct 2024 · 1 like I read the opening post twice before replying, because I had assumed the opposite. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
-
Irish differences from the UK position Replied, post #57 · Regional › UK & Ireland · 25 Oct 2024 · 1 like MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Why I ask for the gradient before I discuss the number Replied, post #23 · Analytics › HPLC & UHPLC · 26 Sep 2024 · 0 likes On post #19 — agreed on the reasoning, with one qualification. Method validation is the demonstration that a method can separate the compound from its degradation…
-
Reporting a discrepancy without making an allegation Replied, post #17 · Sourcing › Vendor reports · 6 Aug 2024 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Guidelines revision: what changed and why Replied, post #119 · Meta › Announcements · 28 Jul 2024 · 0 likes Coming back to post #117, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #120 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #11 · Nutrition & Training › Resistance training · 15 Jun 2024 · 15 likes This follows post #8 rather than contradicting it. Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy…